Friday, November 18, 2022
Print Current Session:
|
|
Friday
SESSION 77:
NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Location: Grand Ballroom East, 3rd Floor
Moderators:Frank J. Veith, MD / Klaus D. Mathias, MD / Sumaira Macdonald, MD, PhD |
|
SESSION 77 SCHEDULE | |
MESH COVERED STENTS | |
7:53 AM - 7:58 AM | Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter |
Presenter(s):Piotr Musialek, MD, DPhil / Max Amor, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:59 AM - 8:04 AM | Update On Carotid And Other Uses Of MicroNet-Covered Stents (C-Guard) In High-Risk Lesions And Aneurysms: What Are The Long-Term Outcomes – And Are There Downsides |
Presenter(s):Piotr Musialek, MD, DPhil / Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
8:05 AM - 8:10 AM | New Multicenter Data Showing The Long-Term Value Of The C-Guard MicroNet Mesh Covered Stent For CAS In High Risk Carotid Lesions (Thrombotic, Calcified And Symptomatic) From The FLOW-GUARD And Other Trials |
Presenter(s):D. Christopher Metzger, MD / Piotr Musialek, MD, DPhil Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:11 AM - 8:16 AM | Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications |
Presenter(s):Francesco Speziale, MD / Gianmarco de Donato, MD / Ashraf Mansour, MD / Pasqualino Sirignano, MD / Carlo Setacci, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
TCAR RELATED TOPICS | |
8:17 AM - 8:22 AM | TCAR Versus Transfemoral CAS (TFCAS) And CEA (Carotid Endarterectomy): From Propensity Matched VQI Studies: What Do They Show Re Stroke, Death And Complication Rates: TCAR Approval Should Be Expanded To Non-High-Risk Patients |
Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:23 AM - 8:28 AM | Real World Single Center (100-Patient Experience) With TCAR: How And Why 30-Day And One Year Outcomes Differ From Those In ROADSTER 1 And ROADSTER 2 |
Presenter(s):Zach AbuRahma, DO / Ali F. AbuRahma, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:29 AM - 8:34 AM | DEBATE: TCAR Is Better Than TFCAS And Brachial/Radial Access For CAS: TCAR Approval Should Be Expanded To Non-High-Risk Patients |
Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:35 AM - 8:40 AM | DEBATE: Not So: TCAR Is No Better And Is More Costly Than TFCAS And Brachial/Radial Access CAS If One Has Appropriate Skills |
Presenter(s):D. Christopher Metzger, MD / William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:41 AM - 8:46 AM | Adjunctive EEG Can Help With TCAR And Decrease The Stroke Rate: When And How |
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:47 AM - 8:52 AM | DEBATE: Based On Data To Date Including 1-Year Results From ROADSTER 2, TCAR Should Replace CEA In Most Cases: When Is TCAR Contraindicated |
Presenter(s):Vikram S. Kashyap, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:53 AM - 8:58 AM | DEBATE: Not So: CEA Is Routinely Better Than TCAR And Remains The Gold Standard: It Should Be Used In Most Cases Requiring Invasive Treatment |
Presenter(s):Michel Makaroun, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:59 AM - 9:07 AM | Panel Discussion |
9:07 AM - 9:17 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 77 | |
previous | next |